Jump to content

VOLT-02

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Marbletan (talk | contribs) at 18:19, 13 March 2023. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
VOLT-02
Clinical data
Other namesProgesterone conjugate
Drug classProgestogen; Neurosteroid
Identifiers
CAS Number

VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders.[1] As of March 2017, it is in phase II clinical trials for these indications.[1] The chemical structure of VOLT-02 does not appear to have been released yet.[1]

See also

[edit]

References

[edit]
  1. ^ a b c "Progesterone conjugate - Levolta Pharmaceuticals - AdisInsight". adisinsight.springer.com.
[edit]